TLPH · Talphera, Inc. · Financials
$1.07
+0.00 (+0.00%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred recurring operating losses and negative cash flows from operating activities since inception and expects to continue to incur operating losses and negative cash flows in the future. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$56.58M
Shares
51.91M
Volume · Oct 21
38.41K
Avg daily vol (3M)
187.27K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$28K
FY2025
Net Income
-$14.29M
-9.9%
FY2025
Gross Margin
-33.18%
-21.8pp
FY2021
Operating Margin
-48157.14%
FY2025
Diluted EPS
-$1.29
-122.6%
FY2023
Operating Cash Flow
-$11.36M
+10.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1000 | $28K | $0 | $651K | $0 | $2.82M | $5.42M | $2.29M | $2.15M | $8M | $17.36M | $19.26M | $5.22M | $29.5M | $2.39M | $1.07M | — | — | — | — | — | |
| — | — | — | — | $2.59M | $3.75M | $6.03M | $6.81M | $3.98M | $10.66M | $12.32M | $1.77M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | -$2.59M | -$935K | -$616K | -$4.52M | -$1.83M | -$2.66M | $5.04M | $17.49M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | -33.18% | -11.37% | -197.34% | -84.84% | -33.32% | 29.05% | 90.81% | — | — | — | — | — | — | — | — | — | |
| $6.7M | $6.03M | $6.72M | $5.55M | $3.34M | $4.1M | $4.02M | $4.66M | $13.14M | $19.41M | $21.4M | $22.49M | $24.52M | $26.29M | $24.91M | $13.62M | $8.19M | $15.5M | — | — | — | |
| — | — | — | — | — | — | — | — | $20.77M | $16.61M | $15.6M | $14.2M | $18.35M | $9.88M | $7.2M | $6.8M | $3.99M | $3.53M | — | — | — | |
| $8.04M | $7.48M | $8.53M | $11.99M | $17.01M | $30.94M | $36.33M | $45.03M | $20.77M | $16.61M | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $0 | $311K | $1.65M | $1.97M | $1.85M | $1.67M | $575K | $1.74M | $2.05M | $1.98M | $866K | $593K | $605K | $513K | $479K | $481K | — | — | — | |
| — | — | — | — | $500K | — | $500K | — | — | — | — | $756K | — | — | — | — | — | — | — | — | — | |
| $56.49M | — | — | — | — | — | — | — | $37.88M | $46.68M | $49.31M | $39.22M | $42.87M | $36.17M | $32.11M | $20.42M | $12.19M | $19.03M | — | — | — | |
| $14.75M | $13.51M | $15.25M | $17.54M | $25.3M | $38.78M | $46.38M | $56.49M | $37.88M | $46.68M | — | — | — | — | — | — | — | — | — | — | — | |
| -$14.75M | -$13.48M | -$15.25M | -$16.89M | -$25.3M | -$35.97M | -$40.96M | -$54.21M | -$35.73M | -$38.68M | -$31.96M | -$19.95M | -$37.65M | -$6.67M | — | — | — | — | — | — | — | |
| — | -48157.14% | — | -2594.32% | — | -1276.26% | -756.33% | -2368.06% | -1660.95% | -483.83% | -184.12% | -103.59% | -721.66% | -22.6% | — | — | — | — | — | — | — | |
| — | — | -$15.25M | -$16.58M | -$23.65M | -$33.99M | -$39.11M | -$52.54M | -$35.15M | -$36.94M | -$29.91M | -$17.97M | -$36.78M | -$6.07M | — | — | — | — | — | — | — | |
| — | — | $0 | $134K | $1.12M | $2.29M | $3.31M | $2.54M | $2.22M | $3.32M | $2.77M | $2.98M | $2.64M | $1.52M | $2.28M | $2.31M | $1.4M | $1.24M | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $52K | $4000 | $33K | — | — | — | |
| -$329K | -$879K | $2.25M | $6.6M | $84.44M | $871K | $588K | $968K | -$11.42M | -$13.53M | -$11.23M | -$3.69M | $4.3M | -$16.76M | -$1.37M | $1.56M | -$761K | $121K | — | — | — | |
| — | — | — | -$10.29M | $59.14M | -$35.09M | -$40.38M | -$53.24M | -$47.15M | -$52.21M | -$43.19M | -$23.64M | -$37.65M | -$6.67M | -$29.71M | -$19.35M | -$12.19M | -$19.03M | — | — | — | |
| — | $0 | $0 | $0 | $13K | $5000 | $4000 | $3000 | $2000 | -$701K | -$34K | $760K | $0 | $0 | $0 | $0 | — | — | — | — | — | |
| -$15.08M | -$14.29M | -$13M | -$18.4M | $47.76M | -$35.1M | -$40.38M | -$53.24M | -$47.15M | -$51.51M | -$43.16M | -$24.4M | -$33.35M | -$23.43M | -$33.36M | -$20.1M | -$14.34M | -$20.12M | -$20.66M | -$9.63M | -$3.77M | |
| — | -51035.71% | — | -2825.96% | — | -1245.53% | -745.55% | -2325.91% | -2191.96% | -644.25% | -248.64% | -126.66% | -639.31% | -79.4% | -1393.61% | -1875.09% | — | — | — | — | — | |
| — | — | — | -$18.4M | $42.33M | -$35.1M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | -$35.1M | -$40.38M | -$53.24M | -$47.15M | -$51.51M | -$43.15M | -$24.4M | -$33.36M | -$23.43M | -$33.36M | -$20.1M | -$14.34M | -$20.16M | -$20.63M | -$9.62M | -$3.77M | |
| USD/shares | -$0.24 | -$0.34 | -$0.50 | -$1.29 | $5.73 | -$5.86 | — | — | — | -$22.00 | -$19.00 | -$11.00 | -$15.40 | -$11.80 | -$30.20 | — | — | — | — | — | — |
| USD/shares | — | — | — | -$1.29 | $5.72 | -$5.86 | — | — | — | -$22.00 | -$19.00 | -$12.00 | -$18.20 | -$11.80 | -$30.20 | — | — | — | — | — | — |
| shares | — | 42.41M | 25.85M | 14.26M | 7.39M | 5.99M | 4.26M | 3.96M | 2.92M | 2.34M | 2.27M | 2.22M | 2.17M | 1.99M | 1.11M | 867.24K | 32.83K | — | — | — | — |
| shares | — | — | — | 14.26M | 7.41M | 5.99M | 4.26M | 3.96M | 2.92M | 2.34M | 2.27M | 2.22M | 2.22M | 1.99M | 1.11M | 867.24K | 32.83K | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of long-term debt | 2023-12-31 | USD 0 | 10-K filed 2024-03-06 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.11×
EV/EBIT
—
Peer median 7.50×
P/E (TTM)
—
Peer medians compare against the 47 similar-size Drug Manufacturers - Specialty & Generic companies (of 101 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Product | $1,771,000 | $1,005,000 | $2,521,000 | $1,830,000 | $825,000 |
| DSUVIA | $1,588,000 | $735,000 | $1,409,000 | $377,000 | $0 |
| DZUVEO | $183,000 | $0 | — | — | — |
| Contract and Other Collaboration | $0 | $1,813,000 | $2,895,000 | $459,000 | $1,326,000 |
| Contract and Other Revenue | $0 | $6,000 | $2,572,000 | $43,000 | $103,000 |
| Non-Cash Royalty | $0 | $83,000 | $242,000 | $312,000 | $289,000 |
| ZALVISO | $0 | $270,000 | $1,112,000 | $1,453,000 | $825,000 |
| License | $0 | $1,696,000 | $0 | — | — |
| Royalty | $0 | $28,000 | $81,000 | $104,000 | $96,000 |
| Amended License Agreement | — | — | $3,683,000 | $1,496,000 | — |
| Department of Defense | — | — | $0 | $0 | $838,000 |